000 04305nam a22003735i 4500
001 80216
003 ES-MaUEC
005 20230207040257.0
007 cr nn 008mamaa
008 140408s2014 xxu| s |||| 0|eng d
020 _a9781461488156
024 7 _a10.1007/978-1-4614-8815-6
_2doi
050 4 _aRC280.H4
_bM654 2014
245 1 0 _aMolecular Determinants of Head and Neck Cancer
_cedited by Barbara Burtness, Erica A. Golemis.
260 _aNew York
_bSpringer
_c2014
300 _a1 recurso en línea (IX, 362 páginas)
_b44 ilustraciones, 40 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aCurrent Cancer Research
505 0 _aOverview: The Pathobiology of Head and Neck Cancer -- Human papillomavirus (HPV)-positive head and neck cancer and the Wnt signaling pathway -- EGFR Inhibitors as Therapeutic Agents in Head and Neck Cancer -- The Role of HGF/c-MET in Head and Neck Squamous Cell Carcinoma -- Insulin-like Growth Factor-1 Receptors in Head and Neck Cancer -- The PI3K Signaling Pathway in Head and Neck Squamous Cell Carcinoma -- Jak/STAT Signaling in HNC -- TGFβ regulates EMT in head and neck cancer -- p53 in Head and Neck Cancer -- DNA damage proteins and response to therapy in head and neck cancer -- Hypoxia and radioresistance in head and neck cancer -- The Wnt β-catenin Signaling Circuitry in Head and Neck Cancer -- Sequencing HNC: Emergence of Notch Signaling -- Gene Expression in HNC -- Epidemiology of HPV in Head and Neck Cancer; variant strains, discrete protein function -- Projections: Novel Therapies for HPV-Negative Cancers of the Head and Neck -- Index.
520 3 _aHead and neck cancers, involving sites from the nasopharynx to the subglottic larynx, are frequently devastating cancers that afflict patients around the world. These cancers are frequently locally advanced prior to detection, and require multimodality therapy that is associated with high morbidity. As this book addresses this difficult disease, it accomplishes three main goals. First, it introduces the etiology and subclasses of squamous cell carcinomas of the head and neck (SCCHNs), and how these factors affect prognosis. Although habitual exposures to tobacco, alcohol, and other agents have historically been the main causes of SCCHN, a rising proportion of oropharynx cancers arise from transforming human papillomavirus (HPV) infection. These two broad classes of SCCHN have significant differences in disease profile and response to treatment, as we discuss. Second, it summarizes the current state of understanding of the genetic, epigenetic and protein expression changes associated with the various classes of SCCHN. In the past decade, disease pathogenesis of SCCHN has been appreciated to involve deregulation of multiple tumor pathways, including the receptor tyrosine kinases (RTKs) EGFR, ERBB2, ERBB3, c-MET, and IGF1R; transforming growth factor β (TGFβ); Notch; cytoplasmic signaling proteins including PTEN, PI3K, JAK/STAT, and Wnt-responsive β-catenin; mutation control systems, including p53 and the DNA damage repair (DDR) machinery; and hypoxic response. The specific understanding of the action of these proteins in SCCHN is presented here. Finally, this book defines potential therapeutic targets for improved management of the disease in the future, discussing prospects for improved prediction of prognosis.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
988 _aEBOOK, asignarmaterias, EBSPRINGER,
650 2 7 _aProteínas
_0
_2embne
_9139861
650 7 _aCuello
_xCáncer
_0(OCoLC)1035351
_2embne
_0
_9210887
700 1 _aBurtness, Barbara
_eeditor literario
_988220
_0Local
700 1 _aGolemis, Erica A.
_eeditor literario
_0Local
_988221
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-8815-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12879691
_b10-10-17
_c11-11-15
998 _am
_a_alco
_a_vill
_b11-11-15
_cm
_dz
_e-
_feng
_gxxu
_h0
945 _aRC280.H4 M654 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11559512
_z06-04-17
999 _c80216
_d80216
_x1